Archive ready

報道発表資料｜厚生労働省

https://www.mhlw.go.jp/stf/newpage_20779.html

April 9, 2026 at 03:01 AM JST•The archive page, viewer, and downloads use this saved version.

April 9, 2026 at 03:01 AM JST·www.mhlw.go.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved page

報道発表資料｜厚生労働省

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.mhlw.go.jp/stf/newpage_20779.html

StartedApril 9, 2026 at 03:01 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page presents the Ministry of Health, Labour and Welfare's press release from August 31, 2021, regarding unannounced inspections of generic drug manufacturing facilities. Following quality issues at generic drug manufacturers, unannounced inspections were conducted at 46 pharmaceutical manufacturing facilities nationwide. Results identified one facility with violations of pharmaceutical law and nine facilities with moderate deficiencies in GMP regulations. Based on the findings, the ministry developed unannounced inspection guidelines and committed to strengthening supervision and guidance in cooperation with prefectural governments.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.